Zachary K. Goldsmith et al. 2024. In Uveal Melanoma, Sirtuin Inhibitor as a New Cell Cycle Checkpoint and TP53-MDM2 Pathway Regulator. The Ophthalmology. (Dec. 2024), 21–30.